Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

PhRMA reaffirms its commitment to support the health reform
The Medical News
Saturday, November 21, 2009 - 12:21pm
tags:
PhRMA, health care reform
Evidence does not connect H1N1 vaccine to patient deaths, WHO says
The Medical News
Saturday, November 21, 2009 - 12:16pm
tags:
H1N1 vaccines
Dithering over statins' side-effects label finally ends
Guardian
Saturday, November 21, 2009 - 12:14pm
tags:
statins
U.S. Court of Appeals Upholds AstraZeneca AWP Settlement
Yahoo/PR NewsWire
Saturday, November 21, 2009 - 12:11pm
tags:
AstraZeneca
Vitamin Beats Statin: Is Merck's Zetia in Trouble?
Seeking Alpha
Saturday, November 21, 2009 - 12:03pm
tags:
Merck, Zetia, Niaspan
Sanofi-Aventis Falling Off a Patent Cliff?
CNBC
Saturday, November 21, 2009 - 12:02pm
tags:
Sanofi
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
Yahoo/BusinessWire
Saturday, November 21, 2009 - 11:52am
tags:
Bristol-Myers Squibb, Abilify, autism
Big Pharma Mergers: Good News Or Bad?
Investors Business Daily
Saturday, November 21, 2009 - 11:50am
tags:
This Baby Is a Nice Addition (Elonva)
Motley Fool
Saturday, November 21, 2009 - 11:25am
tags:
Elonva, Merck, Schering Plough, Follistim
J&J stays true to its diversified model
Financial Times
Saturday, November 21, 2009 - 11:22am
tags:
JNJ
Pfizer's Geodon gets expanded FDA approval
Yahoo/AP
Saturday, November 21, 2009 - 11:19am
tags:
Pfizer, Geodon
Inovio, Merck gain; Novavax falls in afternoon action
MarketWatch
Saturday, November 21, 2009 - 11:16am
tags:
Merck, Inovio, Novavax
Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
PR NewsWire
Saturday, November 21, 2009 - 11:11am
tags:
Cornerstone Therapeutics, Deconsal
May Day For Dendreon
CNBC
Saturday, November 21, 2009 - 11:08am
tags:
Dendreon, Provenge
Provenge Activists Try Again For FDA Documents
Pharmalot
Friday, November 20, 2009 - 11:30am
tags:
Provenge, FDA, prostate cancer, vaccines
4-Star Stocks Poised to Pop: Merck
Motley Fool
Friday, November 20, 2009 - 11:27am
tags:
Merck
Ten Minutes That Mattered: Gilead's Martin
Forbes
Friday, November 20, 2009 - 8:38am
tags:
Gilead Sciences, Pharma CEOs, John Martin
Opponents of Botox Tax Go Big: Baby Boomers! Women!
WSJ Online
Friday, November 20, 2009 - 8:35am
tags:
Allergan, Botox
Possible New Indication for Progenics' Relistor Could Revive Its Fortunes
Seeking Alpha
Friday, November 20, 2009 - 8:28am
tags:
Relistor, Progenics Pharmaceuticals, painkillers
Secret Prempro Documents To Surface In Florida?
Pharmalot
Friday, November 20, 2009 - 8:26am
tags:
Pfizer, Wyeth, Prempro, lawsuits

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.